Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Down 4.8 %

Shares of NYSE:RVP opened at $0.70 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The business’s 50-day moving average is $0.78 and its 200 day moving average is $0.74. The firm has a market capitalization of $21.00 million, a P/E ratio of -1.30 and a beta of 2.08. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.22.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC boosted its holdings in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the quarter. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.